Category: Diagnostics
Global Diagnostics
-
Endoscopic Ultrasound Needles
... at a CAGR of 2.7% over the analysis period 2024-2030. Aspiration Needles (EUS-FNA), one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$150.5 Million by the end ... Read More
-
Legionella Testing
... CAGR of 8.2% over the analysis period 2024-2030. Culture Methods, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$122.4 Million by the end of the analysis ... Read More
-
Microfluidic Device Systems
... at a CAGR of 19.3% over the analysis period 2024-2030. In-vitro Diagnostics End-Use, one of the segments analyzed in the report, is expected to record a 19.3% CAGR and reach US$13.3 Billion by the end ... Read More
-
Ophthalmic Ultrasound Systems
... at a CAGR of 3.9% over the analysis period 2024-2030. Portable Systems, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$2.4 Billion by the end of ... Read More
-
Radiofrequency Ablation Devices for Pain Management
... reach US$1.4 Billion by 2030, growing at a CAGR of 9.9% over the analysis period 2024-2030. Disposable Products, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach ... Read More
-
Veterinary Molecular Diagnostics
... at a CAGR of 7.5% over the analysis period 2024-2030. Instruments & Software, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$342.8 Million by the end ... Read More
-
Teleradiology
... 17.2% over the analysis period 2024-2030. X-ray, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$5.2 Billion by the end of the analysis period. Growth in ... Read More
-
In-Vitro Diagnostics (IVD) Packaging
... 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Bottles, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$4.0 Billion by the end ... Read More
-
Isothermal Nucleic Acid Amplification Technology (INAAT)
... reach US$6.7 Billion by 2030, growing at a CAGR of 10.2% over the analysis period 2024-2030. INAAT Reagents, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach ... Read More
-
Nucleic Acid Isolation and Purification
... Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Nucleic Acid Isolation & Purification Kits, one of the segments analyzed in the report, is expected to record a 5.9% CAGR ... Read More
-
Poultry Diagnostics
... CAGR of 9.0% over the analysis period 2024-2030. ELISATest, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$558.3 Million by the end of the analysis period. ... Read More
-
Service Laboratories
... CAGR of 4.3% over the analysis period 2024-2030. The U.S. Market is Estimated at US$31.3 Billion While China is Forecast to Grow at 4.0% CAGR The Service Laboratories market in the U.S. is estimated at ... Read More
-
Cardiopulmonary Autotransfusion Systems
... at a CAGR of 2.2% over the analysis period 2024-2030. On-Pump Transfusion Device, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$523.8 Million by the end ... Read More
-
Dengue Testing
... CAGR of 4.8% over the analysis period 2024-2030. ELISA-Based Tests, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$383.2 Million by the end of the analysis ... Read More
-
Analytical Laboratory Services
... at a CAGR of 9.0% over the analysis period 2024-2030. Bioanalytical Testing Services, one of the segments analyzed in the report, is expected to record a 9.5% CAGR and reach US$273.4 Million by the end ... Read More
-
Autoimmune Disease Diagnosis
... at a CAGR of 6.0% over the analysis period 2024-2030. Consumables & Assay Kits, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$4.1 Billion by the ... Read More
-
Bio-MEMS Devices
... CAGR of 16.7% over the analysis period 2024-2030. Implantables, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$18.2 Billion by the end of the analysis period. ... Read More
-
Blood Transfusion Devices
... at a CAGR of 5.8% over the analysis period 2024-2030. Pathogen Reduction System, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$3.7 Billion by the end ... Read More
-
Blood Screening
... CAGR of 5.5% over the analysis period 2024-2030. Blood Screening Reagents & Kits, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.7 Billion by the end ... Read More
-
Cancer Diagnostics
... CAGR of 5.8% over the analysis period 2024-2030. Imaging, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$95.3 Billion by the end of the analysis period. ... Read More
-
Nuclear Medicine Imaging Equipment
... 2030, growing at a CAGR of 5.7% over the analysis period 2024-2030. Single-Photon Emission Computed Tomography (SPECT) Systems, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach ... Read More
-
Anatomic Pathology
... CAGR of 5.8% over the analysis period 2024-2030. Anatomic Pathology Services, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$36.4 Billion by the end of the ... Read More
-
Helicobacter Pylori Diagnostics
... at a CAGR of 4.8% over the analysis period 2024-2030. Invasive Test, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$556.8 Million by the end of ... Read More
-
Herpes Marker Testing
... at a CAGR of 4.9% over the analysis period 2024-2030. Antibody / Antigen-Based Kits, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$332.9 Million by the ... Read More
-
Blood Banking and Blood Products
... Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Blood Components & Plasma Products, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and ... Read More
Research Assistance
